NEW YORK (GenomeWeb) – Biocept plans to offer about $15 million of its common stock in a public offering, the firm said in documents filed with the US Securities and Exchange Commission on Wednesday. 

The company has not priced its offering, but said that it plans to offer about 6.3 million shares of its stock. Its shares closed at $2.52 in Wednesday trade on the Nasdaq. 

Aegis Capital and Feltl and Co. are listed as the underwriters on the offering. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.